Research led by Michigan Medicine's Scleroderma Program and published in Arthritis & Rheumatology found that tocilizumab, a FDA-approved anti-inflammatory drug used to combat rheumatoid arthritis, can ...

The drug tofacitinib was well tolerated among patients with early scleroderma, primarily affecting the protein interferon both in fibroblasts and keratinocytes. Researchers say the drug is safe and ...

EARLY DIAGNOSIS of the potentially fatal disease scleroderma is essential if patients are given a chance to survive, a conference was told at the weekend. Scleroderma is an incurable and potentially ...

MONTREAL, January 27, 2026--(BUSINESS WIRE)--Indero is pleased to announce a strategic collaboration with the World Scleroderma Foundation (WSF) to support WSF SHIELD platform trial, a randomized, ...

Scleroderma, a rare autoimmune disease characterized by skin thickening and internal organ fibrosis, has long posed significant therapeutic challenges. With limited treatment options historically ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Detection and treatment of interstitial lung disease in systemic sclerosis calls for early and ...

NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases Ten new research grants on scleroderma (systemic sclerosis) have been funded by the National Institute of Arthritis and ...

Angiotensin-converting enzyme (ACE) inhibitors are the mainstay of therapy for patients with systemic sclerosis in scleroderma renal crisis, however mortality remains high even in the post-ACE ...

Researchers found a unique immune cell plays a key role in the chronic inflammation and scarring in the lungs and skin of people with scleroderma, or systemic sclerosis. After injecting mice with ...